yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q41855293-C74C63EF-F1C5-4533-9BFC-6AAAB56DF979
Q41855293-C74C63EF-F1C5-4533-9BFC-6AAAB56DF979
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41855293-C74C63EF-F1C5-4533-9BFC-6AAAB56DF979
EGFR targeting monoclonal antibody combines with an mTOR inhibitor and potentiates tumor inhibition by acting on complementary signaling hubs.
P2860
Q41855293-C74C63EF-F1C5-4533-9BFC-6AAAB56DF979
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41855293-C74C63EF-F1C5-4533-9BFC-6AAAB56DF979
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4f03e338c479fce7f03587f72bda57b308515454
P2860
Nimotuzumab: a novel anti-EGFR monoclonal antibody that retains anti-EGFR activity while minimizing skin toxicity.